Fulcrum Therapeutics (FULC) Current Assets (2019 - 2025)
Historic Current Assets for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $205.9 million.
- Fulcrum Therapeutics' Current Assets fell 2303.87% to $205.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.9 million, marking a year-over-year decrease of 2303.87%. This contributed to the annual value of $249.9 million for FY2024, which is 318.91% up from last year.
- Per Fulcrum Therapeutics' latest filing, its Current Assets stood at $205.9 million for Q3 2025, which was down 2303.87% from $219.4 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Current Assets peaked at $302.8 million during Q1 2023, and registered a low of $128.5 million during Q2 2021.
- Moreover, its 5-year median value for Current Assets was $227.7 million (2022), whereas its average is $227.4 million.
- As far as peak fluctuations go, Fulcrum Therapeutics' Current Assets surged by 8910.38% in 2021, and later tumbled by 2802.83% in 2024.
- Quarter analysis of 5 years shows Fulcrum Therapeutics' Current Assets stood at $226.0 million in 2021, then dropped by 8.18% to $207.5 million in 2022, then grew by 16.71% to $242.2 million in 2023, then rose by 3.19% to $249.9 million in 2024, then fell by 17.63% to $205.9 million in 2025.
- Its Current Assets stands at $205.9 million for Q3 2025, versus $219.4 million for Q2 2025 and $232.6 million for Q1 2025.